Jean-Michel Andre Vernier

USPTO Granted Patents = 56 (Patent Applications = 22)

CIPO Patents = 7 (Patent Applications = 6)

EPO Patents = 17 (Patent Applications = 25)

Average Co-Inventor Count = 3.2

ph-index = 12

Forward Citations = 505(Granted Patents)

Forward Citations (Not Self Cited) = 475(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Laguna Niguel, CA (US) (2010 - 2015)
San Diego, CA (US) (1996 - 2023)

Company Filing History:

20 out of 63

Ardea Biosciences, Inc

patents

12 out of 22

Valeant Pharmaceuticals International

Sibia Neurosciences, Inc.

patents

5. 4 out of 2,405

Merck Sharp + Dohme Corp.

patents

6. 3 out of 16

Oncternal Therapeutics, Inc.

Bayer Schering Pharma Ag

patents

9. 1 out of 1

Selexagen Therapeutics, Inc.

Years Active: 1996-2024

Loading Chart...

Areas of Expertise:

Tricyclic Pyridones

Thioacetate Compounds

Indolinone Compounds

Hedgehog Inhibitors

Potassium Channel Modulators

MEK Inhibitors

Uric Acid Modulation

mGluR5 Antagonists

Reverse Transcriptase Inhibitors

Benzazole Potentiators

Acetylcholine Receptor Modulators

Fused Heterobicyclic Compounds

56 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12162893 - Tricyclic pyridones and pyrimidones (2024-12-10),

2. 11845761 - Tricyclic pyridones and pyrimidones (2023-12-19),

3. 10919858 - Thioacetate compounds, compositions and methods of use (2021-02-16),

4. 10266493 - Thioacetate compounds, compositions and methods of use (2019-04-23),

5. 9987251 - Indolinone compounds and uses thereof (2018-06-05),

6. 9895352 - Indolinone compounds and uses thereof (2018-02-20),

7. 9604927 - Indolinone compounds and uses thereof (2017-03-28),

8. 9212135 - Phenylthioacetate compounds, compositions and methods of use (2015-12-15),

9. 9174949 - Hedgehog inhibitors (2015-11-03),

10. 8993593 - N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators (2015-03-31),

11. 8829052 - Derivatives of N-(arylamino)sulfonamides as inhibitors of MEK (2014-09-09),

12. 8722929 - N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators (2014-05-13),

13. 8716318 - Pyridone sulfonamides and pyridone sulfamides as MEK inhibitors (2014-05-06),

14. 8673919 - Dihydropyridin sulfonamides and dihydropyridin sulfamides as MEK inhibitors (2014-03-18),

15. 8648116 - Derivatives of N-(arylamino) sulfonamides including polymorphs as inhibitors of MEK as well as compositions, methods of use and methods for preparing the same (2014-02-11),

Title: The Innovative Journey of Jean-Michel Andre Vernier

Introduction: Jean-Michel Andre Vernier is a visionary inventor based in San Diego, CA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Jean-Michel Andre Vernier holds several patents in various technological domains, including advancements in renewable energy, artificial intelligence, and biotechnology.

Career Highlights: With a career spanning over two decades, Jean-Michel Andre Vernier has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have revolutionized industries.

Collaborations: Throughout his career, Jean-Michel Andre Vernier has collaborated with top scientists, engineers, and researchers globally, fostering a culture of innovation and excellence in all his projects.

Conclusion: Jean-Michel Andre Vernier's relentless pursuit of innovation and his passion for pushing the boundaries of technology continue to inspire the next generation of inventors and entrepreneurs worldwide.

This text is generated by artificial intelligence and may not be accurate.